Viewing Study NCT03140332


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT03140332
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2017-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
Sponsor: Centre Hospitalier Universitaire, Amiens
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: PI2016_843_0025
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators